Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3041082	s-gbmif	— (—)	247	283	100.00%	Distribution not available
3041082	s-gbmif	Titteri (titre)	7	14	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

All chronic kidney diseases

126

18.00

134.87

1.2

1.3

438.57

—

titre

—

Renal failure

115

16.39

123.39

1.1

362.00

—

titre

—

Glomerular diseases

25.39

118.89

1.4

1.2

438.57

—

titre

—

All kidney diseases

143

12.30

113.99

1.2

438.57

—

titre

—

Acute renal failure

20.42

88.07

1.1

362.00

—

titre

—

Glomerular disorders in diseases classified elsewhere

39.62

83.44

1.6

1.0

438.57

—

titre

—

Chronic kidney disease

15.21

82.57

1.1

362.00

—

titre

—

ILD medications: immunosuppressive drugs

9.49

72.76

1.2

1.1

510.00

—

titre

—

ILD medications

123

7.21

61.70

1.3

1.1

470.00

—

titre

—

Dialysis, with operation codes

20.63

56.60

1.2

1.0

610.00

—

titre

—

Nephropathy related operations

16.43

52.13

1.2

1.0

610.00

—

titre

—

ILD medications: prednisolone, methylprednisolone, prednisone

108

6.53

51.08

1.3

1.1

470.00

—

titre

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

106

130

5.50

47.25

1.2

—

303.33

—

Systemic connective tissue disorders

7.20

31.29

1.6

1.0

438.57

—

titre

—

Nephrotic syndrome

35.78

22.11

1.0

—

Unspecified kidney failure

26.51

21.31

1.1

1.0

—

Other necrotizing vasculopathies

40.35

19.49

2.2

1.0

438.57

—

titre

—

Heart failure and antihypertensive medication

9.75

16.52

1.0

1.1

—

Autoimmune diseases related-to ILD

169

3.11

14.91

1.5

1.1

438.57

—

titre

—

Other systemic involvement of connective tissue

4.69

9.75

1.0

—

Metabolic disorders

140

2.57

9.37

1.0

1.3

—

303.33

—

Other systemic involvement of connective tissue (FG)

5.78

7.53

1.0

1.1

—

Acute nephritic syndrome

20.22

7.14

1.1

1.0

—

Other arthritis (FG)

3.75

7.06

1.0

1.1

—

Other specified/unspecified systemic involvement of connective tissue

16.73

6.74

1.0

—

Major coronary heart disease event

117

2.35

6.13

1.0

1.3

—

303.33

—

Explicit bacterial Sepsis, including avohilmo

7.66

6.11

1.2

1.4

—

Explicit bacterial Sepsis

8.59

6.05

1.2

1.5

—

Emergency coronary revascularization (for ACS)

123

2.31

6.03

1.0

1.3

—

303.33

—

Other nutritional deficiencies

154

2.31

5.57

1.2

—

303.33

—

Coronary revascularization (ANGIO or CABG)

118

2.26

5.46

1.0

1.3

—

303.33

—

Substance abuse, excluding more controls

116

2.45

5.40

1.1

1.3

—

470.00

—

Streptococcal septicaemia, including avohilmo

6.68

5.25

1.2

1.0

—

Percutaneous Coronary Intervention

118

2.22

5.11

1.0

1.3

—

303.33

—

Persons encountering health services for specific procedures, not carried out

9.02

4.78

1.0

1.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

10.51

4.74

1.0

2.2

—

Injuries to the head

184

1.90

4.72

1.1

1.2

—

438.57

—

Later onset COPD, excluding more controls

6.10

4.72

1.0

—

Streptococcal septicaemia

6.12

4.60

1.2

1.0

—

Obesity

149

2.21

4.59

1.1

1.2

—

303.33

—

Chronic nephritic syndrome

14.05

4.58

1.0

—

Hypertensive Renal Disease

14.05

4.57

1.0

—

Secondary hypertension

8.07

4.51

1.0

—

Obesity and other hyperalimentation

151

2.18

4.44

1.1

1.2

—

303.33

—

Psychiatric diseases

129

1.98

4.40

1.1

1.3

—

438.57

—

Diverticular disease of intestine

2.25

4.36

1.1

1.3

—

303.33

—

Type 1 diabetes

2.88

4.31

1.0

1.2

—

Other CVD (FINNGEN)

7.63

4.17

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

5.17

4.14

1.0

—

Any mental disorder

143

1.89

4.12

1.1

1.3

—

438.57

—

148

2.11

4.10

1.1

—

562.00

—

Seropositive rheumatoid arthritis

4.31

4.09

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

110

2.10

4.04

1.0

1.3

—

303.33

—

COPD (mode)

4.04

3.98

1.0

—

152

2.06

3.95

1.1

—

562.00

—

Substance abuse

152

2.08

3.87

1.1

—

562.00

—

Rare circulating lymphoid malignancy, including Hilmo

7.31

3.86

1.1

1.0

—

Budesonide

5.27

3.82

1.0

—

Ischaemic heart disease, wide definition

2.13

3.80

1.0

1.1

—

362.00

—

Continuous positive airway pressure

4.01

3.75

1.1

1.3

—

Mental and behavioural disorders due to psychoactive substance use

154

2.02

3.61

1.1

—

562.00

—

Symptoms and signs involving the skin and subcutaneous tissue

180

1.94

3.54

1.1

1.2

—

314.00

—

Ischemic heart diseases

118

1.97

3.53

1.1

1.3

—

303.33

—

Elevated blood glucose level

5.30

3.51

1.0

1.2

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

5.30

3.51

1.2

1.1

—

Viral hepatitis, IBD co-morbidity

10.02

3.49

1.0

—

Neurological diseases, wide definition

3.63

3.41

1.1

1.4

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

202

1.77

3.25

1.2

—

438.57

—

Infections of the skin and subcutaneous tissue

176

1.90

3.12

1.1

1.2

—

470.00

—

Cardiomyopathy

3.67

3.08

1.1

—

Molar incisor enamel hypoplasia, with caries

5.06

3.04

1.6

1.5

—

Coronary atherosclerosis

2.08

3.00

1.0

1.1

—

362.00

—

Type 1 diabetes, wide definition, subgroup 1

2.63

2.95

1.0

1.3

—

Myalgia

2.71

1.2

—

Episodal and paroxysmal disorders

165

1.63

2.61

1.1

1.2

—

470.00

—

Type 1 diabetes, wide definition

2.46

2.61

1.0

1.3

—

Oxicams

2.74

2.59

1.4

1.0

—

Hypoplasia of dental enamel

4.42

2.47

1.6

1.5

—

Other diseases of intestines

169

1.61

2.41

1.1

1.2

—

438.57

—

Emphysema

5.01

2.40

1.2

1.1

—

Anxiety (asthma-related co-morbidities)

109

1.88

2.37

1.1

1.3

—

562.00

—

Respiratory insufficiency

6.24

2.36

1.0

1.1

—

Migraine

101

1.93

2.35

1.1

1.4

—

562.00

—

Other disorders of penis

2.94

2.27

1.7

1.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

5.56

2.21

1.0

—

Hypoplasia of dental enamel , including avohilmo

3.10

2.20

1.6

1.3

—

5-aminosalicylic acid

2.78

2.13

1.1

—

Disorders of choroid and retina

151

1.67

2.13

1.1

1.2

—

303.33

—

Molar incisor enamel hypoplasia

2.97

2.11

1.6

1.3

—

Atopic conjunctivitis

5.01

2.07

1.0

—

Neurotic, stress-related and somatoform disorders

167

1.61

2.02

1.1

1.2

—

510.00

—

Vocal cord dysfunction

4.89

2.00

1.0

1.8

—

Anxiety disorders

167

1.60

1.99

1.1

1.2

—

510.00

—

Non-rheumatic valve diseases

1.92

1.70

1.1

1.2

—

Paroxysmal tachycardia

2.52

1.67

1.0

1.3

—

Adjustment and management of implanted device

2.58

1.65

1.3

1.1

—

Exposure to other specified factors

201

1.54

1.65

1.1

1.2

—

438.57

—

Valvular heart disease excluding rheumatic fever

1.86

1.65

1.1

1.2

—

Anxiety disorders, excluding more controls

123

1.61

1.64

1.0

1.3

—

438.57

—

Other functional intestinal disorders

116

1.72

1.58

1.0

1.3

—

470.00

—

Lung cancer and mesothelioma

2.83

1.46

1.0

1.1

—

Fall on same level

186

1.40

1.38

1.1

1.2

—

438.57

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

2.25

1.35

1.1

1.0

—

Benzodiazepine use

182

1.45

1.34

1.0

1.2

—

303.33

—

Sulfasalazine

2.09

1.30

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

180

1.39

1.25

1.1

1.2

—

303.33

—

Childhood asthma (age<16)

2.47

1.25

1.0

1.1

—

Childhood asthma (age<16), excluding more controls

2.47

1.25

1.0

1.1

—

Polymyalgia rheumatica

2.40

1.24

1.0

—

Thiazolidinediones

2.63

1.21

1.0

1.1

—

Open wound of head

153

1.53

1.21

1.2

1.1

—

562.00

—

Mood disorders, excluding more controls

137

1.46

1.21

1.0

1.3

—

438.57

—

Other antidepressants

144

1.42

1.20

1.1

1.2

—

438.57

—

Low back pain

142

1.47

1.19

1.1

1.3

—

303.33

—

Other medical care

1.64

1.19

1.1

—

Fenamates

2.38

1.13

1.1

1.0

—

Non-Hodgkin lymphoma, all, including Hilmo

2.26

1.10

1.0

—

Hernia of abdominal wall, postoperative

2.26

1.02

1.6

1.0

—

Falls/tendency to fall

164

1.34

1.01

1.1

1.2

—

470.00

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.98

0.0

1.0

—

Constipation

178

1.37

0.98

1.0

1.2

—

438.57

—

Allergic asthma (mode), excluding more controls

1.90

0.94

1.4

1.1

—

Selective serotonin reuptake inhibitors

151

1.34

0.91

1.0

1.3

—

438.57

—

Misadventures to patients during surgical and medical care

2.07

0.89

1.0

—

Spondyloarthritis

2.07

0.89

1.0

—

Specific development disorders of scholastic skills

1.96

0.85

1.2

1.4

—

Adhesive capsulitis of shoulder

1.94

0.84

1.2

1.1

—

Pure hypercholesterolaemia

107

1.42

0.83

1.0

1.3

—

303.33

—

Injuries to the ankle and foot

182

1.36

0.82

1.0

1.2

—

438.57

—

Depression or dysthymia

1.42

0.81

1.0

1.3

—

438.57

—

Disorders of tooth development and eruption

1.88

0.81

1.0

—

malignant neoplasm of female genital organs

0.00

0.79

0.0

1.0

—

Motor disorders

0.00

0.79

0.0

1.4

—

Colon adenocarcinoma

0.00

0.78

0.0

1.0

—

Eating disorder

0.00

0.76

0.0

1.1

—

Emotional disorders starting during childhood or adolecense, excluding more controls

2.02

0.73

1.0

1.3

—

Mood [affective] disorders

190

1.28

0.71

1.0

1.2

—

438.57

—

Allergic asthma (mode)

1.75

0.71

1.4

1.1

—

Type 1 diabetes, strict (exclude DM2)

1.75

0.71

1.0

1.3

—

Type 1 diabetes, definitions combined

1.75

0.71

1.0

1.3

—

Depression

176

1.29

0.69

1.0

1.2

—

438.57

—

Trigger finger

1.85

0.68

1.0

1.1

—

Mood disorders

191

1.27

0.68

1.0

1.2

—

438.57

—

Sleep disorders (combined)

179

1.25

0.67

1.0

1.2

—

470.00

—

Diseases of the ear and mastoid process

172

1.25

0.66

1.1

1.2

—

470.00

—

Other diseases of upper respiratory tract

179

1.25

0.66

1.2

1.1

—

510.00

—

Trochanteric bursitis

1.79

0.66

1.0

1.1

—

Valvular operations

1.79

0.66

1.2

1.3

—

Hypopituitarism

1.79

0.66

1.0

1.4

—

Chronic periodontitis, complicated

142

1.37

0.63

1.1

1.2

—

303.33

—

Specific developmental disorder of motor function

0.00

0.60

0.0

1.5

—

Disorders of puberty, all

0.00

0.60

0.0

1.5

—

Other eating disorders

0.00

0.60

0.0

1.1

—

Rheumatism, unspecified

0.00

0.60

0.0

1.1

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

0.00

0.59

0.0

1.0

—

Metatarsalgia

0.00

0.59

0.0

1.1

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.58

0.0

1.1

—

Hyperkinetic disorders (excl. ADHD)

0.00

0.58

0.0

1.4

—

Sleep apnoea

165

1.26

0.57

1.1

1.2

—

314.00

—

Type 1 diabetes, strict definition, subgroup 1

1.71

0.57

1.0

1.3

—

Acute appendicitis

171

1.30

0.56

1.0

1.2

—

438.57

—

Type 1 diabetes, strict definition

1.58

0.54

1.0

1.3

—

Diseases of inner ear

126

0.68

0.51

1.0

1.2

—

314.00

—

Maternal care for known or suspected abnormality of pelvic organs

1.52

0.48

1.0

1.1

—

Conotruncal defects

0.00

0.41

0.0

1.7

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.41

0.0

1.5

—

KRA_PSY_EATING, excluding more controls

0.00

0.41

0.0

1.0

—

Abnormalities of forces of labour

0.00

0.41

0.0

1.0

—

Early lumbar disc prolapse, operated

0.00

0.41

0.0

1.0

—

Polycystic ovarian syndrome, broad definition

0.00

0.41

0.0

1.1

—

Disorders of puberty

0.00

0.40

0.0

1.6

—

AV-block

1.47

0.40

1.2

1.1

—

Pregnancy, childbirth and the puerperium

1.42

0.40

1.1

—

Exclusion endpoint for clefts

0.00

0.40

0.0

1.5

—

Motor disorders, excluding more controls

0.00

0.39

0.0

1.4

—

Emotional disorders starting during childhood or adolescence

1.42

0.39

1.0

1.3

—

Triptan medication for migraine, single purchase ok

153

0.80

0.37

1.2

—

562.00

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

153

0.80

0.37

1.2

—

562.00

—

Type1 diabetes, definitions combined, early onset

1.46

0.36

1.0

1.3

—

Acute appendicitis, no complications

144

1.24

0.33

1.0

1.3

—

562.00

—

Appendicitis, broad definition

182

1.18

0.29

1.0

1.2

—

438.57

—

Diseases of appendix

183

1.17

0.27

1.0

1.2

—

438.57

—

Recurrent or chronic depression

0.72

0.24

1.0

1.5

—

510.00

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.29

0.23

1.0

1.3

—

Excessive attrition of teeth

166

0.83

0.22

1.1

1.2

—

314.00

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.21

0.0

1.3

—

Ectopic testis

0.00

0.21

0.0

1.8

—

Birth asphyxia

0.00

0.21

0.0

1.3

—

Other congenital malformations of male genital organs

0.00

0.21

0.0

1.9

—

Palatinal maxillary canine

0.00

0.21

0.0

1.1

—

Other congenital malformations of male genital organs, including avohilmo

0.00

0.21

0.0

1.8

—

Delayed puberty

0.00

0.21

0.0

1.9

—

Palatinal maxillary operation

0.00

0.21

0.0

1.2

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.21

0.0

1.1

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.21

0.0

1.9

—

Mandibular prognathia

0.00

0.21

0.0

1.9

—

Seronegative juvenile rheumatoid arthritis

0.00

0.21

0.0

1.0

—

Torsion of testis

0.00

0.21

0.0

1.2

—

Patent foramen ovale

0.00

0.21

0.0

1.0

—

Enterobiasis, including avohilmo

0.00

0.21

0.0

1.0

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

0.00

0.21

0.0

1.1

—

Juvenile osteochondrosis

0.00

0.21

0.0

1.1

—

Other disorders of male genital organs

0.00

0.21

0.0

1.0

—

Malignant neoplasm of stomach

0.00

0.21

0.0

1.0

—

Male infertility

0.00

0.21

0.0

1.0

—

Malignant neoplasm of stomach, including Hilmo

0.00

0.21

0.0

1.0

—

Other obstructed labour

0.00

0.21

0.0

1.0

—

Ovarian dysfunction

0.00

0.21

0.0

1.1

—

Abnormal findings on antenatal screening of mother

0.00

0.21

0.0

1.1

—

Female infertility, associated with anovulation

0.00

0.21

0.0

1.0

—

Other disorders originating in the perinatal period

0.00

0.21

0.0

1.2

—

Congenital malformations of the nervous system

0.00

0.21

0.0

1.7

—

Congenital deformities of hip

0.00

0.21

0.0

1.3

—

Malignant neoplasm of brain, including Hilmo

0.00

0.21

0.0

1.0

—

Multiple delivery

0.00

0.21

0.0

1.1

—

Malignant neoplasm of corpus uteri

0.00

0.21

0.0

1.0

—

Twin gestation

0.00

0.21

0.0

1.0

—

Slow fetal growth and fetal malnutrition

0.00

0.21

0.0

1.6

—

Congenital deformities of hip, including avohilmo

0.00

0.21

0.0

1.2

—

Other sexually transmitted chlamydial diseases

0.00

0.21

0.0

1.1

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.21

0.0

1.1

—

Multiple gestation

0.00

0.21

0.0

1.0

—

Other infections specific to the perinatal period

0.00

0.20

0.0

1.8

—

Isolated growth hormone deficiency

0.00

0.20

0.0

1.6

—

Early lumbar disc prolapse operation

0.00

0.20

0.0

1.0

—

Open wound of wrist and hand

137

0.85

0.17

1.0

1.1

—

562.00

—

Injuries to the wrist and hand

212

1.09

0.16

1.1

1.2

—

438.57

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.76

0.16

1.0

—

Persons encountering health services in circumstances related to reproduction

130

0.88

0.16

1.2

1.3

—

362.00

—

Behavioural syndromes associated with physiological disturbances and physical factors

197

0.93

0.10

1.1

1.2

—

438.57

—

Sleep apnoea, including avohilmo

169

1.07

0.10

1.1

1.2

—

470.00

—

Chronic diseases of tonsils and adenoids

149

1.06

0.05

1.4

1.1

—

510.00

—

Symptoms and signs involving the nervous and musculoskeletal systems

169

1.06

0.05

1.1

1.2

—

314.00

—

Sleep disorders

184

0.97

0.01

1.1

1.2

—

438.57

—

Hernia

175

1.02

0.00

1.2

—

438.57

—

Necrosis of pulp, including avohilmo

150

0.99

0.00

1.1

1.3

—

314.00

—

Fracture of lower leg, including ankle

155

1.01

0.00

1.0

1.3

—

314.00

—

Insomnia

178

1.02

0.00

1.1

1.2

—

438.57

—

Cholecystectomy

142

1.02

0.00

1.0

1.2

—

314.00

—

Precocious central puberty

0.00

0.0

1.0

—

Renal cell carcinoma of kidney

0.00

0.0

1.0

—

Endocrine disorders, other/unspecified

0.00

0.0

1.0

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.0

1.0

—

Other congenital malformations of skull and face bones

0.00

0.0

1.0

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

0.0

1.1

—

Other congenital malformations of limb(s)

0.00

0.0

1.0

—

Right ventricular outflow tract obstruction

0.00

0.0

1.2

—

Allergic contact dermatitis due to drugs in contact with skin

0.00

0.0

1.0

—

Malignant neoplasm of ovary

0.00

0.0

1.0

—

Other abnormal immunological findings in serum

0.00

0.0

1.0

—

Congenital malformations of spine and bony thorax, including avohilmo

0.00

0.0

1.0

—

Granulomatous disorders of skin and subcutaneous tissue

0.00

0.0

1.0

—

Coarctation of the aorta

0.00

0.0

2.4

—

Mandibular retrognathia AND surgery (BSSO)

0.00

0.0

1.0

—

Other and unspecified hydrocephalus

0.00

0.0

1.0

—

Disorder of the sleep-wake schedule

0.00

0.0

1.0

—

Periodontal disease, other/unspecified

0.00

0.0

1.0

—

Precocious puberty

0.00

0.0

1.0

—

Undescended testis, unilateral

0.00

-0.00

0.0

2.0

—

Acetic acid derivatives and related substances

0.86

-0.00

1.0

—

Mesial bite

0.00

-0.00

0.0

1.3

—

Other congenital musculoskeletal deformities, including avohilmo

0.00

-0.00

0.0

1.0

—

Single ventricle heart

0.00

-0.00

0.0

1.0

—

Other congenital malformations of intestine

0.00

-0.00

0.0

1.1

—

Moderate visual impairment, binocular

0.00

-0.00

0.0

1.2

—

Congenital vesicoureteral reflux

0.00

-0.00

0.0

1.3

—

Serous carcinoma of ovary, including Hilmo

0.00

-0.00

0.0

1.0

—

Congenital aortic valve stenosis

0.00

-0.00

0.0

2.2

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.0

—

Congenital malformations of eyelid, lacrimal apparatus and orbit

0.00

-0.00

0.0

1.0

—

Other congenital malformations of intestine, including avohilmo

0.00

-0.00

0.0

1.1

—

Congenital dislocation of hip, unilateral

0.00

-0.00

0.0

1.0

—

Deep bite that required surgery

0.00

-0.00

0.0

1.0

—

Other specified disorders of muscle

0.00

-0.00

0.0

1.1

—

Muscle strain

0.00

-0.00

0.0

1.0

—

Patellar tendinitis

0.00

-0.00

0.0

1.0

—

Congenital stenosis of pulmonary valve

0.00

-0.00

0.0

1.0

—

Chronic respiratory disease originating in the perinatal period

0.00

-0.00

0.0

2.4

—

Other perinatal haematological disorders

0.00

-0.00

0.0

1.0

—

Other disturbances of cerebral status of newborn

0.00

-0.00

0.0

1.0

—

Hereditary retinal dystrophy

0.00

-0.00

0.0

1.0

—

Feeding problems of newborn

0.00

-0.00

0.0

1.2

—

0.00

-0.00

0.0

1.0

—

Bilateral sagittal split ramus osteotomy operation

0.00

-0.00

0.0

1.0

—

Asymmetry of jaw

0.00

-0.00

0.0

1.0

—

Perioral dermatitis

0.00

-0.00

0.0

1.0

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Radial styloid tenosynovitis [de Quervain]

0.00

-0.00

0.0

1.1

—

Juvenile rheumatoid arthirtis

0.00

-0.00

0.0

1.0

—

Delivery, wide proxy

1.00

-0.00

1.0

1.1

—

Inflammatory disorders of breast

0.00

-0.00

0.0

1.0

—

Congenital malformations of cardiac chambers and connections

0.00

-0.00

0.0

1.1

—

Fetus and newborn affected by other complications of labour and delivery

0.00

-0.00

0.0

1.0

—

Cyst of Bartholin Gland

0.00

-0.00

0.0

1.0

—

Congenital malformations of eyelid, lacrimal apparatus and orbit, including avohilmo

0.00

-0.00

0.0

1.0

—

Congenital malformations of gallbladder, bile ducts and liver

0.00

-0.00

0.0

1.1

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

0.00

-0.00

0.0

1.0

—

Unspecified abortion

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Bicipital tendinitis

0.00

-0.00

0.0

1.0

—

Excessive vomiting in pregnancy

0.00

-0.00

0.0

1.0

—

Other inflammation of vagina/vulva

0.00

-0.00

0.0

1.0

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.0

—

Social disorders starting during childhood or adolescence

0.00

-0.00

0.0

1.3

—

Postpartum haemorrhage due to anatomy

0.00

-0.00

0.0

1.0

—

Other obstetric trauma

0.00

-0.00

0.0

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.02

-0.00

1.0

—

Maxillary prognathism

0.00

-0.00

0.0

1.0

—

Primary Sclerosing Cholangitis, IBD and UDCA required

0.00

-0.00

0.0

1.1

—

Other demyelinating diseases of the central nervous system

0.00

-0.00

0.0

1.0

—

Acute myeloid leukaemia and myelodysplastic syndromes

0.00

-0.00

0.0

1.0

—

Adenocarcinoma and papillary adenocarcinoma of stomach

0.00

-0.00

0.0

1.0

—

Unspecified visual impairment (binocular)

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

0.00

-0.00

0.0

1.0

—

Constitutional tall stature

0.00

-0.00

0.0

2.2

—

Drug-induced adrenocortical insufficiency

0.00

-0.00

0.0

1.0

—

Other benign neoplasms of uterus

0.00

-0.00

0.0

1.1

—

Other chromosome abnormalities, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Hypoparathyroidism

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of eye, brain and central nervous system

0.00

-0.00

0.0

1.0

—

Congenital malformations of pulmonary and tricuspid valves

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of brain

0.00

-0.00

0.0

1.0

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

0.00

-0.00

0.0

1.0

—

Other congenital malformations of heart

0.00

-0.00

0.0

1.0

—

Other congenital malformations of ear

0.00

-0.00

0.0

1.0

—

Conduction disorders

0.89

-0.00

1.2

—

Benign neoplasm: Skin of lower limb, including hip

0.00

-0.00

0.0

1.0

—

Testicular hypofunction

0.00

-0.00

0.0

1.0

—

Moderate mental retardation

0.00

-0.00

0.0

1.0

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

0.00

-0.00

0.0

1.2

—

Complex cardiac defects

0.00

-0.00

0.0

1.0

—

Generalized epilepsy, strict definition

0.00

-0.00

0.0

1.2

—

Other congenital malformations of kidney

0.00

-0.00

0.0

1.2

—

Other puerperal infections

0.00

-0.00

0.0

1.1

—

Other congenital malformations of peripheral vascular system

0.00

-0.00

0.0

1.0

—

Disorders of puberty, other/unspecified

0.00

-0.00

0.0

1.2

—

Congenital malformation of biliary tract

0.00

-0.00

0.0

1.1

—

Social disorders starting during childhood or adolecense, excluding more controls

0.00

-0.00

0.0

2.0

—

Personal history of risk-factors, not elsewhere classified

0.00

-0.00

0.0

1.3

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

-0.00

0.0

1.0

—

Family history of other conditions

0.00

-0.00

0.0

1.0

—

Other maltreatment syndromes

0.00

-0.00

0.0

1.0

—

Exposure to other and unspecified man-made environmental factors

0.00

-0.00

0.0

1.0

—

Intentional self-harm by unspecified means

0.00

-0.00

0.0

1.1

—

Exposure to other specified electric current

0.00

-0.00

0.0

1.0

—

Burn and corrosion of ankle and foot

0.00

-0.00

0.0

1.0

—

Polycystic ovarian syndrome

0.00

-0.00

0.0

1.1

—

Complications of other internal prosthetic devices, implants and grafts

0.00

-0.00

0.0

1.2

—

Superficial injury of neck

0.00

-0.00

0.0

1.0

—

Gender identity disorders

0.00

-0.00

0.0

1.3

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

1.0

—

Other and unspecified corneal deformities and disorders

0.00

-0.00

0.0

1.0

—

Essential (haemorrhagic) thrombocythaemia

0.00

-0.00

0.0

1.0

—

Vascular dementia (undefined)

0.00

-0.00

0.0

1.2

—

Burn and corrosion of head and neck

0.00

-0.00

0.0

1.0

—

Certolizumab pegol

0.00

-0.00

0.0

1.0

—

Other and unspecified acne

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS